Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Johnson and Johnson
Moodys
Express Scripts
Cipla
Federal Trade Commission
Dow
Fish and Richardson

Generated: May 21, 2018

DrugPatentWatch Database Preview

Validus Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for VALIDUS PHARMS, and when can generic versions of VALIDUS PHARMS drugs launch?

VALIDUS PHARMS has eight approved drugs.

There is one US patent protecting VALIDUS PHARMS drugs.

There is one patent family member on VALIDUS PHARMS drugs in one country.

Summary for Validus Pharms
International Patents:1
US Patents:1
Tradenames:5
Ingredients:5
NDAs:8

Drugs and US Patents for Validus Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Validus Pharms EQUETRO carbamazepine CAPSULE, EXTENDED RELEASE;ORAL 021710-003 Dec 10, 2004 RX Yes Yes 6,977,253 ➤ Try a Free Trial ➤ Try a Free Trial
Validus Pharms EQUETRO carbamazepine CAPSULE, EXTENDED RELEASE;ORAL 021710-001 Dec 10, 2004 RX Yes No 6,977,253 ➤ Try a Free Trial ➤ Try a Free Trial
Validus Pharms NIFEDIPINE nifedipine CAPSULE;ORAL 073250-001 Oct 8, 1991 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-003 Jun 14, 1985 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Validus Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-003 Jun 14, 1985 3,806,534 ➤ Try a Free Trial
Validus Pharms ROCALTROL calcitriol CAPSULE;ORAL 018044-001 Approved Prior to Jan 1, 1982 3,697,559 ➤ Try a Free Trial
Validus Pharms EQUETRO carbamazepine CAPSULE, EXTENDED RELEASE;ORAL 021710-002 Dec 10, 2004 5,326,570 ➤ Try a Free Trial
Validus Pharms EQUETRO carbamazepine CAPSULE, EXTENDED RELEASE;ORAL 021710-001 Dec 10, 2004 5,326,570 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for VALIDUS PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Capsules 200 mg and 300 mg ➤ Subscribe 2007-08-21
➤ Subscribe Extended-release Capsules 100 mg ➤ Subscribe 2014-05-23

International Patents for Validus Pharms Drugs

Country Document Number Estimated Expiration
Canada 2452588 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Healthtrust
Cerilliant
UBS
Medtronic
Dow
Cipla
US Department of Justice
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.